Skip to content

Clinical trials

Phase 2 Joint Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Joint Diseases Phase: Phase 2 Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20061
20092
20101
20112
20133
20142
20151
20161
20181
20193
20202
20212
20223
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated4
Withdrawn3
Unknown status2
Not yet recruiting2
Recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
BioCryst Pharmaceuticals2
Celgene2
Amgen1
Bioxtract SA1
Cara Therapeutics, Inc.1
Eli Lilly and Company1
Forward Therapeutics1
Icahn School of Medicine at Mount Sinai1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Joint Diseases32
Arthritis22
Musculoskeletal Diseases14
Osteoarthritis11
Rheumatic Diseases10
Arthritis, Rheumatoid8
Autoimmune Diseases6
Osteoarthritis, Knee5
Connective Tissue Diseases4
Immune System Diseases3

Trials

Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.